Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
The aim of this work is to establish novel strategies for the highly sensitive screening of cancer biomarkers in biological samples.To achieve this goal, we developed droplet-based microfluidic dPCR technique. Using a limiting dilution, individual DNA molecules are encapsulated within monodisperse d...
Main Author: | |
---|---|
Language: | English |
Published: |
Université de Strasbourg
2013
|
Subjects: | |
Online Access: | http://tel.archives-ouvertes.fr/tel-00856594 http://tel.archives-ouvertes.fr/docs/00/85/65/94/PDF/PEKIN_Deniz_2013_ED222.pdf |
id |
ndltd-CCSD-oai-tel.archives-ouvertes.fr-tel-00856594 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-CCSD-oai-tel.archives-ouvertes.fr-tel-008565942014-10-14T03:30:50Z http://tel.archives-ouvertes.fr/tel-00856594 2013STRAF007 http://tel.archives-ouvertes.fr/docs/00/85/65/94/PDF/PEKIN_Deniz_2013_ED222.pdf Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer Pekin, Deniz [SDV:AEN] Life Sciences/Food and Nutrition [SDV:AEN] Sciences du Vivant/Alimentation et Nutrition [SDV:SA] Life Sciences/Agricultural sciences [SDV:SA] Sciences du Vivant/Sciences agricoles Droplet microfluidics Cancer biomarkers Digital PCR The aim of this work is to establish novel strategies for the highly sensitive screening of cancer biomarkers in biological samples.To achieve this goal, we developed droplet-based microfluidic dPCR technique. Using a limiting dilution, individual DNA molecules are encapsulated within monodisperse droplets of a water-in-oil emulsion created with a microfluidic device. Fluorescent TaqMan® probes targeting the screened cancer biomarkers allow the detection of mutations. We focused on the mutations in the human KRAS gene for the development of our test. This method is also transposable in a multiplexed format for the parallel detection of multiple mutations in clinical samples.The developed technique allowed the precise quantification of a mutated KRAS gene in the presence of a 200,000-fold excess of un-mutated KRAS genes and enabled the determination of mutant allelic specific imbalance (MASI) in several cancer cell-lines. We validated our technique by screening for KRAS mutations in the blood plasma and tumor samples from patients with metastatic colorectal cancer. 2013-02-26 eng PhD thesis Université de Strasbourg |
collection |
NDLTD |
language |
English |
sources |
NDLTD |
topic |
[SDV:AEN] Life Sciences/Food and Nutrition [SDV:AEN] Sciences du Vivant/Alimentation et Nutrition [SDV:SA] Life Sciences/Agricultural sciences [SDV:SA] Sciences du Vivant/Sciences agricoles Droplet microfluidics Cancer biomarkers Digital PCR |
spellingShingle |
[SDV:AEN] Life Sciences/Food and Nutrition [SDV:AEN] Sciences du Vivant/Alimentation et Nutrition [SDV:SA] Life Sciences/Agricultural sciences [SDV:SA] Sciences du Vivant/Sciences agricoles Droplet microfluidics Cancer biomarkers Digital PCR Pekin, Deniz Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer |
description |
The aim of this work is to establish novel strategies for the highly sensitive screening of cancer biomarkers in biological samples.To achieve this goal, we developed droplet-based microfluidic dPCR technique. Using a limiting dilution, individual DNA molecules are encapsulated within monodisperse droplets of a water-in-oil emulsion created with a microfluidic device. Fluorescent TaqMan® probes targeting the screened cancer biomarkers allow the detection of mutations. We focused on the mutations in the human KRAS gene for the development of our test. This method is also transposable in a multiplexed format for the parallel detection of multiple mutations in clinical samples.The developed technique allowed the precise quantification of a mutated KRAS gene in the presence of a 200,000-fold excess of un-mutated KRAS genes and enabled the determination of mutant allelic specific imbalance (MASI) in several cancer cell-lines. We validated our technique by screening for KRAS mutations in the blood plasma and tumor samples from patients with metastatic colorectal cancer. |
author |
Pekin, Deniz |
author_facet |
Pekin, Deniz |
author_sort |
Pekin, Deniz |
title |
Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer |
title_short |
Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer |
title_full |
Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer |
title_fullStr |
Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer |
title_full_unstemmed |
Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer |
title_sort |
development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer |
publisher |
Université de Strasbourg |
publishDate |
2013 |
url |
http://tel.archives-ouvertes.fr/tel-00856594 http://tel.archives-ouvertes.fr/docs/00/85/65/94/PDF/PEKIN_Deniz_2013_ED222.pdf |
work_keys_str_mv |
AT pekindeniz developmentofnoveldropletbasedmicrofluidicstrategiesforthemoleculardiagnosisofcancer |
_version_ |
1716717033489432576 |